More than 5,000 products were suspended from the Internet, and those that met these conditions were cleared out by the market on a large scale!

Pharmaceutical Network July 8th, since the 4-7 national expansion of the siege, the collection of unselected drug prices to adjust or suspend the policy of hanging the network spread in various placesFrom August 1, Jiangsu Province will also suspend or withdraw the hanging network processing of 5318 products, in addition to 12327 drugs in the province in accordance with the requirements of the adjustment of the price of the network, not so many products involved in Jiangsu this time?From August 1st, Jiangsu Province will suspend or withdraw the processing of 5318 products!On July 3, the Jiangsu Provincial Public Resources Trading Center issued a Notice on the Publication of the Results of the Suspension of the Classification of Drugs on the Internet, suspending or withdrawing the processing of 5318 drugs, including omeprazole, proschatyane, ntikavir, yew alcohol, kramycin, hydrochloric acid sitliolian, ebersatin, cold sepsis and other larger and more common varietiesJiangsu Province pointed out in the above notice, in order to improve the drugprocurementsystem in Jiangsu Province, to play the drug procurement price dynamic adjustment of the drug production enterprises in the same products, different regions to form a unified price of the role of the promotion, reduce some of the false high variety prices, decided to Jiangsu Province, the centralized procurement of drugs in the catalog of some of the drug provincial shortlist prices to carry out dynamic adjustmentThe suspension of the network can be traced back to 2019 In Jiangsu Province to collect catalog drug prices for dynamic adjustment of the workIt is worth noting that Jiangsu Province requires price adjustment of drugs not only 4 plus 7 in the expansion of the unselected products, including the 2015 Jiangsu Province collection of drugs, covering a wide rangeFor the price of the products not selected for the collection and expansion, there are three dynamic adjustments in three situations:is the original research drug, the reference preparation, the quality and efficacy consistency evaluation of generic drugs not selected drugsFor drugs that have completed the gradient price reduction, in accordance with the "4 plus 7" pilot cities and the pilot expansion area after the gradient price reduction as the upper limit, the production enterprises independently declare the price of the network, encourage enterprises to reduce the price independently;Second, the non-selected drugs of generic drugs were not evaluated by quality and efficacy consistencyTo the national provincial (district, city) is the lowest price in the implementation of the lowest price and the low price of the harvest, the lowest price as the upper limit, the production enterprises independently declare the price of the networkThird, the same varieties of drugs through the quality and efficacy consistency evaluation of the production enterprises reached more than 3, not through the quality and efficacy consistency evaluation of generic drugs suspended hanging networkAfter the evaluation of the required products listed in the provincial shortlist, the price dynamic adjustment of the product to replace the original provincial finalistsFor the 2015 Jiangsu Province drug centralized procurement catalog of some drugs: that is, the use of large drugs, small-scale drugs, low-cost drugs, recorded drugs, alternative drugs and through the quality of consistency evaluation of drugs, innovative drugs to adjust, requiring the lowest prices in the current implementation prices of the country's provinces, to encourage enterprises to independently reduce prices, different specifications should maintain a reasonable price comparison, otherwise will be leveled After evaluation, the current provincial finalist price scored adjustment 　　It is reported that the adjustment was launched on November 29, 2019, requiring the relevant production enterprises to declare by December 16, 2019 the lowest price (referred to as the lowest price in the country) at all provinces (autonomous regions and municipalities directly under the central government) 　　Since then, Jiangsu Province in late 2019 and mid-April this year, respectively, to give enterprises two opportunities to make up the report In the end, 12327 drug adjusted the price of the hook-up network according to the requirements, an average decrease of 5.54%, the adjusted price has been implemented from June 1, 2020; 　　The number of drugs announced on the suspension of the network is not low, reaching 5318, on August 1st officially suspended the network For these suspended drugs, Jiangsu Province will be classified treatment, a total of nine cases, but in fact, most of the main factors are still in the price and consistency evaluation: (i) the same variety through the consistency evaluation of enterprises reached more than 3 outstanding drugs: suspension of related drugs hanging network, through consistency evaluation can be re-declared 　　(2) The national minimum price is the through consistency evaluation of the pre-evaluation price of the drug: temporarily restore the relevant drug online qualification, but it must take the initiative to complete the national minimum price leveling, and fail to complete the price leveling in time, in accordance with the provisions of the treatment 　　(3) The minimum packaging price as the minimum formulation unit price declared as drugs: after conversion, the minimum formulation unit quotation of the relevant drug meets the requirements of dynamic adjustment, and in accordance with the provisions of the dynamic adjustment notice, restores its registration to the net, and hangs the price of the minimum formulation unit after conversion 　　(4) Failing consistent evaluation of drugs whose declared price is higher than the selected price in the national collection and collection: Suspend the relevant drug network If the relevant drug is willing to adjust the price to the price requirement for the unselected drug, the qualification of the hanging net may be restored 　　(5) Drugs that are clinically necessary, irreplaceable and at high risk of shortage after expert demonstration: Invite all production enterprises of generic drugs corresponding to the relevant drugs to carry out negotiations on the stability of supply and price, and effectively safeguard the demand for clinical drug use In order to ensure the supply of clinical drugs, the relevant drug network will be temporarily restored before the outcome of the negotiations is produced 　　(6) Drugs that have not been sold in Jiangsu for one year: revoking the qualification of the relevant drugs to hang up the net After the cancellation of the hanging net, the relevant production enterprises may re-declare the hanging net in accordance with the relevant provisions 　　(7) Drugs that have no sales time of less than 1 year in Jiangsu Province: Suspend the relevant drug network and revoke its registration after 1 year without the time of sale After the cancellation of the hanging net, the relevant production enterprises may re-declare the hanging net in accordance with the relevant provisions 　　(8) Drugs that have not filled in the lowest price in the country and have not explained the reasons: revoking the qualification of the relevant drugs to hang up the net Within one year from the date of its revocation of the hanging net, the application for the hanging net of the enterprise of the type shall not be accepted; 　　(9) Drugs that need to be further sent to verify the price: the price of the relevant drug complaint spartauny price is invalid, further letter shall be sent to the relevant provinces for verification, and after the situation has been verified, the procurement shall be suspended during the verification period 　　National collection and outer varieties have also been suspended hanging network
with the third round of national collection and local collection of the rush, consistency evaluation and price linkage is still the of pharmaceutical enterprises pressure 　　Previously for the product simply do not do consistency evaluation of the problem of how much space, from the current Measures of Jiangsu Province on more than 10,000 products, the degree of squeeze in the hospital is growing, and with some areas will be drugstore into the collection and not selected products outside the hospital action, the space outside the market will also be more intense 　　In June this year, Hubei Province Health Insurance Bureau also on the national collection of unselected products for price adjustment and suspension of the network, and finally, more than 1000 drugs were suspended 　　But Jiangsu this time different point is, not only to the national collection of varieties to implement adjustments, but also in 2015 Jiangsu collection varieties into the price adjustment and suspension of the scope of the network It can be seen that the price is also gradually becoming after the consistency evaluation of the first phase-out of the important factors, and the obsolete varieties are rapidly to the national collection of varieties outside